Coral Genomics
New clinical tests for managing autoimmune treatments.
已被收購
公司介紹
公司介紹（英文原文）
Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases.
We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
主題
- 團隊規模
- 5 名員工
- YC 梯次
- Summer 2018
- 狀態
- 已被收購
- 階段
- 早期階段
